Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
4(80.0%)
N/A
1(20.0%)
5Total
Phase 4(4)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06605469Recruiting

Ejaculatory and Orgasmic Dysfunction Registry

Role: lead

NCT05108558Phase 4Active Not Recruiting

Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders

Role: lead

NCT04786106Phase 4Active Not Recruiting

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

Role: lead

NCT05244486Not ApplicableRecruiting

Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy

Role: lead

NCT04788823Phase 4Active Not Recruiting

The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal

Role: lead

NCT06649539Phase 4Recruiting

Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease

Role: lead

All 6 trials loaded